Comparison of the GPVI inhibitors losartan and honokiol

Losartan and honokiol are small molecules which have been described to inhibit aggregation of platelets by collagen. Losartan has been proposed to block clustering of GPVI but not to affect binding of collagen. Honokiol has been reported to bind directly to GPVI but only at a concentration that is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Onselaer, Marie-Blanche, Nagy, Magdolna, Pallini, Chiara, Pike, Jeremy A, Perrella, Gina, Quintanilla, Lourdes Garcia, Eble, Johannes A, Poulter, Natalie S., Heemskerk, Johan W.M., Watson, Steve P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034533/
https://www.ncbi.nlm.nih.gov/pubmed/30849265
http://dx.doi.org/10.1080/09537104.2019.1585526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034533/
https://www.ncbi.nlm.nih.gov/pubmed/30849265
http://dx.doi.org/10.1080/09537104.2019.1585526

Ejemplares similares